The BCL-2 promoter (-938C>A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia (Q80113982)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

The BCL-2 promoter (-938C>A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

chronic lymphocytic leukemia

28 December 2019

main subject

1 reference

Kaderi MA

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Norberg M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Murray F

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Merup M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Sundström C

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Roos G

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Aleskog A

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Karlsson K

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Axelsson T

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Tobin G

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Rosenquist R

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

29 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

339-343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18046447%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2405042

28 December 2019

exact match

0 references

cites work

Chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

Over-expression of cyclin D1 in chronic B-cell malignancies with abnormality of chromosome 11q13

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

A clinical staging system for chronic lymphocytic leukemia: prognostic significance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

Molecular detection of the G(-248)A BAX promoter nucleotide change in B cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

The P2X7 receptor gene polymorphism 1513 A→C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl‐2 family protein expression or survival in B‐cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

The GNAS1 T393C polymorphism and lack of clinical prognostic value in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

Bcl-2 and the regulation of programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

The proto-oncogene Bcl-2 and its role in regulating apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

A negative regulatory element in the bcl-2 5'-untranslated region inhibits expression from an upstream promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

Homogeneous genotyping assays for single nucleotide polymorphisms with fluorescence resonance energy transfer detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021

Identification of variants in cyclin D1 ( CCND1) and B-Cell CLL/lymphoma 2 ( BCL2).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405042

7 January 2021